Acute organ injury and long-term sequelae of severe pneumococcal infections

Katherine L Kruckow1, Kevin Zhao2, Dawn M E Bowdish2

  • 1Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Insights

Streptococcus pneumoniae (Spn) causes severe illness and long-term health issues. Survivors face reduced quality of life and life expectancy due to organ damage from pneumococcal disease.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Streptococcus pneumoniae (Spn) is a significant global health concern.
  • It causes serious conditions like pneumonia, meningitis, and sepsis.
  • Acute Spn infections lead to organ damage with lasting effects.

Purpose of the Study:

  • To review evidence on long-term sequelae of pneumococcal disease.
  • To highlight the impact of Spn infection on survivors' quality of life and life expectancy.

Main Methods:

  • Literature review of studies on pneumococcal disease outcomes.
  • Analysis of data on organ damage and long-term morbidities post-infection.

Main Results:

  • Pneumococcal infections cause organ damage through bacterial toxins, stress, and inflammation.
  • Survivors experience new or worsened chronic conditions (COPD, heart disease, neurological impairments).
  • Current mortality statistics underestimate the long-term impact of pneumococcal disease.

Conclusions:

  • Damage from acute Spn infection results in chronic sequelae.
  • These sequelae significantly reduce survivors' quality of life and life expectancy.
  • A comprehensive understanding of Spn's long-term effects is crucial for public health strategies.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
297
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
328
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
391
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
280
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
243
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
411